Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Cardiff Oncology Inc (CRDF)  
$1.22 0.00 (0.00%) as of 4:30 Tue 6/2


Download
   
Exchange: Over The Counter
Security Type: Common
Shares Out: 35,320,000
Market Cap: 42.91(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $1.215 - $1.215
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Cardiff Oncology is a clinical-stage, oncology therapeutics company, taking a medicine approach to target KRAS-mutated metastatic colorectal cancer, metastatic castrate-resistant prostate cancer and acute myeloid leukemia. Co.'s drug candidate, onvansertib, is an oral and highly-selective Polo-like Kinase 1 (PLK1) adenosine triphosphate competitive inhibitor. PLK1 is essential for regulating the cell division and maintaining genome stability in mitosis (cell division), spindle assembly, and DNA damage response. Co.'s intellectual property and proprietary technology enables it to analyze circulating tumor DNA and clinically actionable markers for predicting response to cancer therapies.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 30,000 52,950 280,950
Total Buy Value $0 $41,100 $63,591 $443,027
Total People Bought 0 1 1 6
Total Buy Transactions 0 1 2 8
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-02-11 2023-11-10 2023-05-12 2022-05-12

   
Records found: 108
  Page 3 of 5  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Erlander Mark Chief Scientific Officer   •       –      –    2019-01-01 4 OE $0.00 $0 D/D 7,500 21,180     -
   Erlander Mark Chief Scientific Officer   •       –      –    2018-10-01 4 D $0.00 $0 D/D (2,731) 13,680     -
   Erlander Mark Chief Scientific Officer   •       –      –    2018-10-01 4 OE $0.00 $0 D/D 7,500 16,411     -
   Markin Rodney S Director   –       •      –    2018-06-20 4/A B $0.85 $35,020 D/D 41,200 43,085 2.39     -
   Markin Rodney S Director   –       •      –    2018-06-20 4 B $0.85 $35,020 D/D 41,200 63,810 2.39     -
   Brancaccio John P Director   –       •      –    2018-06-08 4/A B $0.80 $8,000 D/D 10,000 13,598 2.39     -
   Tennant Stanley Director   –       •      –    2018-06-08 4/A B $0.80 $8,000 D/D 10,000 28,839 2.39     -
   Tennant Stanley Director   –       •      –    2018-06-08 4 B $0.80 $8,000 D/D 10,000 236,061 2.39     -
   Brancaccio John P Director   –       •      –    2018-06-08 4 B $0.80 $8,000 D/D 10,000 53,167 2.39     -
   Welch William J Chief Executive Officer   •       •      –    2018-01-30 4 D $0.00 $0 D/D (62,010) 842,645     -
   Welch William J Chief Executive Officer   •       •      –    2018-01-30 4 OE $0.00 $0 D/D 130,000 904,655     -
   Erlander Mark Chief Scientific Officer   •       –      –    2018-01-30 4 D $0.00 $0 D/D (42,930) 104,367     -
   Erlander Mark Chief Scientific Officer   •       –      –    2018-01-30 4 OE $0.00 $0 D/D 90,000 147,297     -
   Erlander Mark Chief Scientific Officer   •       –      –    2018-01-02 4 D $0.00 $0 D/D (9,558) 57,243     -
   Erlander Mark Chief Scientific Officer   •       –      –    2018-01-02 4 OE $0.00 $0 D/D 18,750 66,801     -
   Adams Thomas Phd Director   –       •      –    2018-01-02 4 OE $0.00 $0 D/D 16,667 351,959     -
   Jacob Gary S Director   –       •      –    2018-01-02 4 OE $0.00 $0 D/D 16,667 148,954     -
   Welch William J Chief Executive Officer   •       •      –    2018-01-02 4 D $0.00 $0 D/D (25,487) 769,905     -
   Welch William J Chief Executive Officer   •       •      –    2018-01-02 4 OE $0.00 $0 D/D 50,000 795,392     -
   Tennant Stanley Director   –       •      –    2018-01-02 4/A OE $0.00 $0 D/D 16,667 226,061     -
   Tennant Stanley Director   –       •      –    2018-01-02 4 OE $0.00 $0 D/D 16,667 234,545     -
   Billings Paul Director   –       •      –    2018-01-02 4 OE $0.00 $0 D/D 16,667 16,667     -
   Billings Paul Director   –       •      –    2018-01-02 4/A OE $0.00 $0 D/D 16,667 23,165     -
   Welch William J Chief Executive Officer   •       •      –    2018-01-02 4/A D $0.00 $0 D/D (25,487) 774,655     -
   Welch William J Chief Executive Officer   •       •      –    2018-01-02 4/A OE $0.00 $0 D/D 50,000 800,142     -
  108 Records found
  1  2  3  4  5   
  Page 3 of 5
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us